{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:18:58Z","timestamp":1791400738493,"version":"4.3.3"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>Can preimplantation genetic testing for aneuploidy (PGT-A) improve the live birth rate in patients with recurrent pregnancy loss (RPL)?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>PGT-A use was associated with improved live birth rates in couples with recurrent pregnancy loss undergoing frozen embryo transfer (IVF-FET).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Euploid embryo transfer is thought to optimize outcomes in some couples with infertility. There is insufficient evidence, however, supporting this approach to management of recurrent pregnancy loss.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This study included data collected by the Society of Assisted Reproductive Technologies Clinical Outcomes Reporting System (SART-CORS) for IVF-FET cycles between years 2010 through 2016. A total of 12\u00a0631 FET cycles in 10\u00a0060 couples were included in this analysis designed to assess the utility of PGT-A in couples with RPL undergoing FET, including 4287 cycles in couples with tubal disease who formed a control group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>The experimental group included couples with RPL (strictly defined as a history of 3 or more pregnancy losses) undergoing FET with or without PGT-A. The primary outcome was live birth rate. Secondary outcomes included rates of clinical pregnancy, spontaneous abortion, and biochemical pregnancy loss. Differences were analyzed using generalized estimating equations logistic regression models to account for multiple cycles per patient. Covariates included in the model were age, gravidity, geographic region, race\/ethnicity, smoking history, and indication for assisted reproductive technologies. Analyses were stratified for age groups as defined by SART: &amp;lt;35\u2009years, 35\u201337\u2009years, 38\u201340\u2009years, 41\u201342\u2009years, and &amp;gt;42\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>In women with a diagnosis of RPL, the adjusted odds ratio (OR) comparing IVF-FET with PGT-A versus without PGT-A for live birth outcome was 1.31 (95% CI: 1.12, 1.52) for age &amp;lt;35\u2009years, 1.45 (95% CI: 1.21, 1.75) for ages 35\u201337\u2009years, 1.89 (95% CI: 1.56, 2.29) for ages 38\u201340, 2.62 (95% CI: 1.94\u20133.53) for ages 41\u201342, and 3.80 (95% CI: 2.52, 5.72) for ages &amp;gt;42\u2009years. For clinical pregnancy, the OR was 1.26 (95% CI: 1.08, 1.48) for age &amp;lt;35\u2009years, 1.37 (95% CI: 1.14, 1.64) for ages 35\u201337\u2009years, 1.68 (95% CI: 1.40, 2.03) for ages 38\u201340\u2009years, 2.19 (95% CI: 1.65, 2.90) for ages 41\u201342, and 2.31 (95% CI: 1.60, 3.32) for ages &amp;gt;42\u2009years. Finally, for spontaneous abortion, the OR was 0.95 (95% CI: 0.74, 1.21) for age &amp;lt;35\u2009years, 0.85 (95% CI: 0.65, 1.11) for ages 35\u201337\u2009years, 0.81 (95% CI: 0.60, 1.08) for ages 38\u201340, 0.86 (95% CI: 0.58, 1.27) for ages 41\u201342, and 0.58 (95% CI: 0.32, 1.07) for ages &amp;gt;42\u2009years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The retrospective collection of data including only women with recurrent pregnancy loss undergoing FET presents a limitation of this study, and results may not be generalizable to all couples with recurrent pregnancy loss. Also, data regarding evaluation and treatment for RPL for the included women is unavailable.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>This is the largest study to date assessing the utility of PGT-A in women with RPL. PGT-A was associated with improvement in live birth and clinical pregnancy in women with RPL, with the largest difference noted in the group of women with age greater than 42\u2009years. Couples with RPL warrant counseling on all management options to reduce subsequent miscarriage, which may include IVF with PGT-A for euploid embryo selection.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>There are no conflicts of interest to declare.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>N\/A.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deab117","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:44:15Z","timestamp":1619138655000},"page":"2339-2344","source":"Crossref","is-referenced-by-count":91,"title":["Pregnancy outcomes following <i>in vitro<\/i> fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study"],"prefix":"10.1093","volume":"36","author":[{"given":"S J","family":"Bhatt","sequence":"first","affiliation":[{"name":"Reproductive Gynecology and Infertility, Akron, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-4811","authenticated-orcid":false,"given":"N M","family":"Marchetto","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, Rutgers New Jersey Medical School, Newark, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Morelli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, Rutgers New Jersey Medical School, Newark, NJ, USA"},{"name":"University Reproductive Associates, Hasbrouck Heights, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P G","family":"McGovern","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Women\u2019s Health, Rutgers New Jersey Medical School, Newark, NJ, USA"},{"name":"University Reproductive Associates, Hasbrouck Heights, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"2021071920002043400_deab117-B1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/humrep\/14.5.1243","article-title":"Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies","volume":"14","author":"Camus","year":"1999","journal-title":"Hum Reprod"},{"key":"2021071920002043400_deab117-B2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.fertnstert.2015.10.018","article-title":"Outcomes of in vitro fertilization with preimplantation genetic diagnosis: an analysis of the United States Assisted Reproductive Technology Surveillance Data, 2011\u20132012","volume":"105","author":"Chang","year":"2016","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2015.08.038","article-title":"Comprehensive chromosome screening improves embryo selection: a meta-analysis","volume":"104","author":"Dahdouh","year":"2015","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B4","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.fertnstert.2016.01.025","article-title":"Effects of maternal age on euploidy rates in a large cohort of embryos analyzed with 24-chromosome single-nucleotide polymorphism-based preimplantation genetic screening","volume":"105","author":"Demko","year":"2016","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B5","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1399-0004.2009.01273.x","article-title":"Preimplantation genetic diagnosis","volume":"76","author":"Geraedts","year":"2009","journal-title":"Clin Genet"},{"key":"2021071920002043400_deab117-B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.fertnstert.2016.02.026","article-title":"Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011\u20132012","volume":"106","author":"Kushnir","year":"2016","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0015-0282(16)47475-3","article-title":"The relationship of tubal blockage, infertility of unknown cause, suspected male infertility, and endometriosis to success of in vitro fertilization and embryo transfer","volume":"40","author":"Mahadevan","year":"1983","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B8","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/humrep\/dew135","article-title":"Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss","volume":"31","author":"Murugappan","year":"2016","journal-title":"Hum Reprod"},{"key":"2021071920002043400_deab117-B9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/humrep\/deh664","article-title":"Pregnancy outcome after IVF and ICSI in unexplained, endometriosis-associated and tubal factor infertility","volume":"20","author":"Omland","year":"2005","journal-title":"Human Reproduction"},{"key":"2021071920002043400_deab117-B10","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/humrep\/16.12.2587","article-title":"Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility","volume":"16","author":"Omland","year":"2001","journal-title":"Human Reprod"},{"key":"2021071920002043400_deab117-B11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.fertnstert.2012.09.023","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"99","author":"Practice Committee of American Society for Reproductive Medicine","year":"2013","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B12","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2012","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","article-title":"The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion","volume":"109","author":"Practice Committees of the American Society for Reproductive Medicine and Society for Assisted Reproductive Technology","year":"2018","journal-title":"Fertil Steril"},{"key":"2021071920002043400_deab117-B14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/humrep\/dew311","article-title":"PGS for recurrent pregnancy loss: still an open question","volume":"32","author":"Rienzi","year":"2017","journal-title":"Hum Reprod"},{"key":"2021071920002043400_deab117-B15","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/humrep\/dez229","article-title":"Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure","volume":"34","author":"Sato","year":"2019","journal-title":"Hum Reprod"},{"key":"2021071920002043400_deab117-B16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s10815-016-0785-2","article-title":"Pre-implantation genetic testing in ART: who will benefit and what is the evidence?","volume":"33","author":"Vaiarelli","year":"2016","journal-title":"J Assist Reprod Genet"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/8\/2339\/39118872\/deab117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/36\/8\/2339\/39118872\/deab117.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T20:01:59Z","timestamp":1626724919000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/36\/8\/2339\/6282627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,5,24]]},"published-print":{"date-parts":[[2021,7,19]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab117","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2021,5,24]]}}}